GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS.

about

Cardiac arrhythmia and heart failure: From bench to bedside Cell and gene therapy for arrhythmias: Repair of cardiac conduction damage

P2860

Q36077254-BEA5BDF8-BD2A-435A-B1FC-426FDC2A19BD Q36077259-48C8C00E-054F-497C-B5E0-3BCD1A7E4C6A

P2860

GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS.

Item

http://www.wikidata.org/entity/Q39282470

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS.

@en

GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS.

@nl

type

Item

label

GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS.

@en

GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS.

@nl

prefLabel

GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS.

@en

GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS.

@nl

P1476

GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS

@en

P2093

Michael R Rosen

http://www.w3.org/2001/XMLSchema#string

Peter Danilo

http://www.w3.org/2001/XMLSchema#string

Richard B Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation

Cardiac conduction through engineered tissue.

The consequences of disrupting cardiac inwardly rectifying K(+) current (I(K1)) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes.

Molecular ablation of ventricular tachycardia after myocardial infarction.

Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy.

Prophylactic catheter ablation for the prevention of defibrillator therapy

Experimental models of ventricular tachycardia and fibrillation caused by ischemia and infarction.

Epicardial border zone overexpression of skeletal muscle sodium channel SkM1 normalizes activation, preserves conduction, and suppresses ventricular arrhythmia: an in silico, in vivo, in vitro study.

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.

Electromechanical integration of cardiomyocytes derived from human embryonic stem cells.

P304

44-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20191107

http://www.w3.org/2001/XMLSchema#string

P932

2828741

http://www.w3.org/2001/XMLSchema#string

GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS.

about

P2860

P2860

GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932